Product
Overview
1.1. Market
Definition
1.2. Scope
of the Market
1.2.1. Markets
Covered
1.2.2. Years
Considered for Study
1.2.3. Key
Market Segmentations
2. Research
Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive
Summary
3.1. Overview
of the Market
3.2. Overview
of Key Market Segmentations
3.3. Overview
of Key Market Players
3.4. Overview
of Key Regions/Countries
3.5. Overview
of Market Drivers, Challenges, Trends
4. Voice
of Customer
5. Global
Gene Editing Technologies Market Outlook
5.1. Market
Size & Forecast
5.1.1. By
Value
5.2. Market
Share & Forecast
5.2.1. By
Offerings (Gene Editing Products, Gene Editing Services)
5.2.1.1. By
Gene Editing Products (Kits and Enzymes, Antibodies, Libraries, Accessories)
5.2.2. By
Technology (CRISPR Gene Editing Technology, Non-CRISPR Gene Editing Technology
(Zinc-Finger Nucleases (ZFNs), TAL Effector Nucleases (TALENs), Meganucleases)
5.2.3. By
Application (Agricultural, Biomedical (Drug Discovery, Gene Therapy,
Diagnostics))
5.2.4. By
End User (Academic Institutes and Research Centers, Life Sciences Companies,
Contract Research Organizations (CROs)/Contract Manufacturing Organizations
(CMOs))
5.2.5. By
Region (North America, Europe, Asia Pacific, South America, Middle East, and
Africa)
5.2.6. By
Company (2023)
5.3. Market
Map
5.3.1. By
Offerings
5.3.2. By
Technology
5.3.3. By
Application
5.3.4. By
End User
5.3.5. By
Region
6. North
America Gene Editing Technologies Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1. By
Offerings
6.2.2. By
Technology
6.2.3. By
Application
6.2.4. By
End User
6.2.5. By Country
6.3. North
America: Country Analysis
6.3.1. United
States Gene Editing Technologies Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By
Offerings
6.3.1.2.2. By
Technology
6.3.1.2.3. By
Application
6.3.1.2.4. By
End User
6.3.2. Canada
Gene Editing Technologies Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By
Offerings
6.3.2.2.2. By
Technology
6.3.2.2.3. By
Application
6.3.2.2.4. By
End User
6.3.3. Mexico
Gene Editing Technologies Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By
Offerings
6.3.3.2.2. By
Technology
6.3.3.2.3. By
Application
6.3.3.2.4. By
End User
7. Europe
Gene Editing Technologies Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1. By
Offerings
7.2.2. By
Technology
7.2.3. By
Application
7.2.4. By
End User
7.2.5. By
Country
7.3. Europe:
Country Analysis
7.3.1. Germany
Gene Editing Technologies Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By
Offerings
7.3.1.2.2. By
Technology
7.3.1.2.3. By
Application
7.3.1.2.4. By
End User
7.3.2. France
Gene Editing Technologies Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By
Offerings
7.3.2.2.2. By
Technology
7.3.2.2.3. By
Application
7.3.2.2.4. By
End User
7.3.3. United
Kingdom Gene Editing Technologies Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By
Offerings
7.3.3.2.2. By
Technology
7.3.3.2.3. By
Application
7.3.3.2.4. By
End User
7.3.4. Italy
Gene Editing Technologies Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By
Offerings
7.3.4.2.2. By
Technology
7.3.4.2.3. By
Application
7.3.4.2.4. By
End User
7.3.5. Spain
Gene Editing Technologies Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By
Offerings
7.3.5.2.2. By
Technology
7.3.5.2.3. By
Application
7.3.5.2.4. By
End User
8. Asia-Pacific
Gene Editing Technologies Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1. By
Offerings
8.2.2. By
Technology
8.2.3. By
Application
8.2.4. By
End User
8.2.5. By
Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China
Gene Editing Technologies Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By
Offerings
8.3.1.2.2. By
Technology
8.3.1.2.3. By
Application
8.3.1.2.4. By
End User
8.3.2. Japan
Gene Editing Technologies Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By
Offerings
8.3.2.2.2. By
Technology
8.3.2.2.3. By
Application
8.3.2.2.4. By
End User
8.3.3. India
Gene Editing Technologies Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By
Offerings
8.3.3.2.2. By
Technology
8.3.3.2.3. By
Application
8.3.3.2.4. By
End User
8.3.4. South
Korea Gene Editing Technologies Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By
Offerings
8.3.4.2.2. By
Technology
8.3.4.2.3. By
Application
8.3.4.2.4. By
End User
8.3.5. Australia
Gene Editing Technologies Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By
Offerings
8.3.5.2.2. By
Technology
8.3.5.2.3. By
Application
8.3.5.2.4. By
End User
9. South
America Gene Editing Technologies Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1. By
Offerings
9.2.2. By
Technology
9.2.3. By
Application
9.2.4. By
End User
9.2.5. By
Country
9.3. South
America: Country Analysis
9.3.1. Brazil
Gene Editing Technologies Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By
Offerings
9.3.1.2.2. By
Technology
9.3.1.2.3. By
Application
9.3.1.2.4. By
End User
9.3.2. Argentina
Gene Editing Technologies Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By
Offerings
9.3.2.2.2. By
Technology
9.3.2.2.3. By
Application
9.3.2.2.4. By
End User
9.3.3. Colombia
Gene Editing Technologies Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By
Offerings
9.3.3.2.2. By
Technology
9.3.3.2.3. By
Application
9.3.3.2.4. By
End User
10. Middle
East and Africa Gene Editing Technologies Market Outlook
10.1. Market
Size & Forecast
10.1.1. By
Value
10.2. Market
Share & Forecast
10.2.1. By
Offerings
10.2.2. By
Technology
10.2.3. By
Application
10.2.4. By
End User
10.2.5. By
Country
10.3. MEA:
Country Analysis
10.3.1. UAE
Gene Editing Technologies Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By
Offerings
10.3.1.2.2. By
Technology
10.3.1.2.3. By
Application
10.3.1.2.4. By
End User
10.3.2. Saudi
Arabia Gene Editing Technologies Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By
Offerings
10.3.2.2.2. By
Technology
10.3.2.2.3. By
Application
10.3.2.2.4. By
End User
10.3.3. South
Africa Gene Editing Technologies Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By
Offerings
10.3.3.2.2. By
Technology
10.3.3.2.3. By
Application
10.3.3.2.4. By
End User
11. Market
Dynamics
11.1. Drivers
11.2. Challenges
12. Market
Trends & Developments
13. Competitive
Landscape
13.1. Addgene
Inc.
13.1.1.
Business Overview
13.1.2. Product Offerings
13.1.3. Recent Developments
13.1.4. Financials (In Case of Listed Companies)
13.1.5. Key Personnel
13.2. BRAIN Biotech AG
13.3. Cellectis S.A.
13.4. Creative Biolabs, Inc.
13.5. CRISPR Therapeutics AG
13.6. DNA Script SAS
13.7. Gene Copoeia, Inc.
13.8.
Merck KgaA
13.9. PerkinElmer Inc.
13.10. BioRad Laboratories Inc.
14. Strategic Recommendations
15. About
Us & Disclaimer